New antibiotic shows promise for newborns with dangerous infections
NCT ID NCT06086626
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how the antibiotic cefiderocol works in hospitalized infants under 3 months old with suspected or confirmed gram-negative bacterial infections. Researchers measured drug levels in the blood and checked for side effects in 30 babies. The goal was to find the right dose and ensure safety, not to prove the drug cures the infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cefiderocol (an antibiotic given intravenously)
What this could lead to
If successful, this could provide a new antibiotic option for hard-to-treat bacterial infections in very young infants.
What could go wrong
This is a small, early-phase study focused on safety and dosing, not on proving the drug works. It may not lead to a new standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GRAM-NEGATIVE BACTERIAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arkansas Children's Hospital
Little Rock, Arkansas, 72202, United States
-
Chang Gung Memorial Hospital, Linkou Department of Pediatrics
Taoyuan City, 333, Taiwan
-
Duke University
Durham, North Carolina, 27705, United States
-
Tygerberg Hospital
Cape Town, Western Cape, 8000, South Africa